Geron Corporation

US$0.99As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GERNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.05%)
Div yield —
ROE (20.12%)
Biotechnology
Beta (5Y) 0.61
PE TTM —
TSR TTM (21.44%)
Mkt cap US$637.7M
ROIC (2.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.14
15.46%
30.80%
Hold 2|10|6|10|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
0.19%
(9.66%)
(4.98%)
(2.83%)
Revenue$M
55.21
57.81
59.07
57.71
13.45%
18.41%
15.51%
8.28%
Peers (US$637.7M)
Cap (US$)
PE
628.6M
1.778x
Capital
TTM
5Y
10Y
Leveragex
1.013
—
—
EBIT/Intx
9.574
0.238
0.220
Own earn%
(112.60)
3.12
5.81
Sh yield%
28.18
22.94
27.41
Owners
Insiders/Inst%
3.56
67.28
Short interest%
4.47
SBC / revenue%
3.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
20–25
$1 testx
0.0
Incr. ROIC%
11